机构

• 广州生物医药与健康研... [2]
• 合肥物质科学研究院 [2]

采集方式

• OAI收割 [4]

内容类型

• 期刊论文 [4]

发表日期

• 2021 [1]
• 2020 [1]
• 2013 [2]

学科主题

• Pharmacolo... [2]

筛选

浏览/检索结果: 共4条，第1-4条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 ITER Equatorial Port #12 Assembly-System design, development, testing and assurance (vol 160, 112025, 2020) 期刊论文  OAI收割 FUSION ENGINEERING AND DESIGN, 2021, 卷号: 167 作者:     |  收藏  |  浏览/下载：20/0  |  提交时间：2021/08/31 ITER Equatorial Port #12 Assembly-System design, development, testing and assurance 期刊论文  OAI收割 FUSION ENGINEERING AND DESIGN, 2020, 卷号: 160 作者:  She, Yupeng;  Hu, Qingsheng;  Wang, Min;  Zhao, Junyu;  Huang, Suzhen   |  收藏  |  浏览/下载：26/0  |  提交时间：2021/04/26 ITER  Equatorial Port  Integration design  Quality assurance   Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2013, 卷号: 56, 期号: 3 作者:  Wang, Deping;  Feng, Yubing;  Zhuang, Xiaoxi;  Zhang, Fengxiang;  Liu, Jianqi   |  收藏  |  浏览/下载：27/0  |  提交时间：2018/12/13 Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2013, 卷号: 56, 期号: 3 Ren, Xiaomei; Pan, Xiaofen; Zhang, Zhang; Wang, Deping; Lu, Xiaoyun; Li, Yupeng; Wen, Donghai; Long, Huoyou; Luo, Jinfeng; Feng, Yubing; Zhuang, Xiaoxi; Zhang, Fengxiang; Liu, Jianqi; Leng, Fang; Lang, Xingfen; Bai, Yang; She, Miaoqin; Tu, Zhengchao; Pan, Jingxuan; Ding, Ke 收藏  |  浏览/下载：28/0  |  提交时间：2016/12/16